<back

Meeting Topic: "Innovative Funding for Life Science Companies: Texas Emerging Technology Fund and Royalty Financing"

Speaker:
Jason Moore
Manager, Industry Programs
BioHouston, Inc.

Jason is responsible for a range of programs designed to increase Houston's momentum in technology commercialization, including teaching the Biotech 101 course, chairing/facilitating regional committees related to regulatory affairs, technology transfer and human resources, managing the organization's Pharma Partnering Program, and managing the member benefits portfolio.

Prior to joining BioHouston, Jason was responsible for a broad range of new-drug development and registration activities in all stages of development for both established and emerging biotechnology companies, primarily focused on oncology and infectious diseases. Jason's specific expertise is in drug development and strategic project management at the portfolio level. Among those companies are Amgen, Antigenics, Aronex Pharmaceuticals and Introgen Therapeutics. He has been a consultant in regulatory affairs, strategy and medical writing for biotechnology companies and academic research labs engaged in new drug development. He holds an M.S. in medical writing from Texas A&M University and an M.B.A. from the University of Houston C.T. Bauer College of Business.

Speaker:
Julie Klim
Principal
Capital Royalty L.P.

Julie Klim co-founded Capital Royalty in 2003. Prior to joining Capital Royalty, Ms. Klim was Director, Worldwide Business Development for GlaxoSmithKline Pharmaceuticals (GSK), the second-largest pharmaceutical company in the world with 2004 revenues of over $38 billion.

Ms. Klim has extensive experience in the pharmaceutical industry and particularly in pharmaceutical licensing. Ms. Klim was a member of the Worldwide Business Development team of SmithKlineBeecham plc prior to SmithKline's merger with Glaxo Wellcome plc in 2000. She has successfully negotiated licensing and co-promotion deals with multinational pharmaceutical companies, biotechnology companies, drug delivery companies, and individual inventors across a broad range of therapeutic areas including metabolic, anti-viral and oncology.

Prior to joining SmithKline Beecham in 1996, Ms. Klim was a financial analyst and internal auditor for Johnson Matthey, plc a precious metals trader and manufacturer. From 1990 to 1994, Ms. Klim worked in the public accounting industry as an auditor for Coopers & Lybrand in Philadelphia, PA.

Ms. Klim graduated with a Bachelor of Science in Accounting degree from The Pennsylvania State University in 1990.

Date/Time:
Tuesday, October 4, 2005
7:00 am - 8:30 am

Location:
Crowne Plaza
6701 South Main St.
Houston, Texas 77030
713.797.1110
Map and Driving Information

Pricing: Includes Hospitality and Parking
$15 - Members with online reservations
$20 - Members with no reservations or non-members with online reservations
$25 - Non-members with no reservations

Reminder: Time to check your membership expiration date listed in your online account profile. An active membership provides premium discounts on meeting fees.

Reservations:
Registration Closed

Note: Online reservation requires all members AND non-members to setup an account on the BMTC web site.

Payments by cash or check prior to the event are to be mailed to:
BMTC
P.O. Box 66488
Houston, TX 77266-6488

No-show reservations will be billed.

Day of Event Registration:
On site registrations are welcome the day of the event. Payment on site is by
cash or check only. Correct change is appreciated.

Thank you and we look forward to seeing you at this event.

Bio/Medical Technology Club of Houston
www.bmtchouston.org

 

[return to top]